FindTrial
Sign In

Efficacy evaluation of new HPV test to improve cervical cancer screening

A PROBE (Prospective-specimen-collection and retrospective blinded-evaluation) study of HPV viral load to improve cervical cancer screening

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
CRIS
Registry ID
KCT0009466
Enrollment
3000
Registered
2024-05-24
Start date
2017-03-27
Completion date
Unknown
Last updated
2024-05-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

None listed

Sponsors

CHA University
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: 1. Cervical cytology shows atypical squamous cell (ASC) or low grade squamous cell endothelial lesion (LSIL) or normal human papillomavirus (HPV) 16 or 18 infection 2. the patients who signed an approved subject consent form 3. the patients aged 21 years or older

Exclusion criteria

Exclusion criteria: 1. Patients who have previously been diagnosed with cervical cancer and precancerous lesions of the cervix and have been treated 2. Patient who is pregnant 3. Histology types other than squamous cells, linear cells and linear epithelial cells

Design outcomes

Primary

MeasureTime frame
Comparison of HPV quantitative test results with histological results—

Secondary

MeasureTime frame
Positive predictive value of each high-risk HPV type—

Countries

Korea, Republic of

Contacts

Public ContactJu-Won Roh

CHA University

rohjuwon@hanmail.net+82-31-782-8615

Outcome results

None listed

Source: CRIS (via WHO ICTRP) · Data processed: Feb 4, 2026